|EKMR, 29.05.1998 - 40900/98|
- EGMR, 27.05.2008 - 26565/05
N. ./. Vereinigtes Königreich36. In Karara v. Finland, no. 40900/98, Commission decision of 29 May 1998, the applicant, a citizen of Uganda, had been treated in Finland for an.
..." 2 See B.B. v. France, judgment of 7 September 1998, Reports of Judgments and Decisions 1998-VI; Karara v. Finland, no. 40900/98, Commission decision of 29 May 1998: illness had not yet reached an advanced stage; S.C.C. v. Sweden (dec.), no 46553/99, 15 February 2000: same type of AIDS treatment as in Sweden was available in Zambia, although at a considerable cost, but the applicant's children and family members lived there; Bensaid v. the United Kingdom, no. 44599/98, ECHR 2001-I: medical treatment available in Algeria, not receiving support or care to a large extent speculative; Henao v. The Netherlands (dec.), no. 13669/03, 24 June 2003: applicant's illness had not reached an advanced or terminal stage and he had a prospect of medical care and family support in his country of origin; Ndangoya v. Sweden (dec.), no. 17868/03, 22 June 2004: applicant's illness had not reached an advanced or terminal stage and adequate treatment was to be found in Tanzania, albeit at considerable cost and with limited availability in the rural area from whence the applicant came, and he maintained some links with relatives who might be able to help him; Amegnigan v. the Netherlands (dec.), no. 25629/04, 25 November 2004: applicant had not reached the stage of full-blown AIDS and was not suffering from any HIV- related illnesses and adequate treatment was in principle available in Togo albeit at a possibly considerable cost.
- EGMR, 22.12.2008 - 46468/06
ALEKSANYAN v. RUSSIAThe Court is aware of the fact that modern anti-retroviral drugs remain very expensive (see, mutatis mutandis, the cases of Karara v. Finland, no. 40900/98, Commission decision of 29 May 1998; see also S.C.C. v. Sweden (dec.), no. 46553/99, 15 February 2000; and Arcila Henao v. The Netherlands (dec.), no. 13669/03, 24 June 2003).
Neu: Die Merklistenfunktion erreichen Sie nun über das Lesezeichen oben.